Prevention of PPROM: Current and future strategies

References

• Lee R M, Major C A. Controversial and special situations in the management of preterm premature rupture of membranes. Clin Perinatol 2001; 28: 877–884
   PubMedGoogle Scholar
• Mercer B M, Goldenberg R L, Meis P J, Moawad A H, Shellhaas C, Das A, Menard M K, Caritis S N, Thurnau G R, Dombrowski M P, et al. The Preterm Prediction Study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 2000; 183: 738–745
   PubMed Web of Science ®Google Scholar
• Harger J H, Hsing A W, Tuomala R E, Gibbs R S, Mead P B, Eschenbach D A, Knox G E, Polk B F. Risk factors for preterm premature rupture of fetal membranes: A multicenter case–control study. Am J Obstet Gynecol 1990; 163: 130–137
   PubMed Web of Science ®Google Scholar
• Ekwo E E, Gosselink C A, Woolson R, Moawad A. Risks for premature rupture of amniotic membranes. Int J Epidemiol 1993; 22: 495–503
   PubMed Web of Science ®Google Scholar
• Odibo A O, Talucci M, Berghella V. Prediction of preterm premature rupture of membranes by transvaginal ultrasound features and risk factors in a high-risk population. Ultrasound Obstet Gynecol 2002; 20: 245–251
   PubMedGoogle Scholar
• Siega-Riz A M, Promislow J H, Savitz D A, Thorp J M, McDonald T. Vitamin C intake and the risk of preterm delivery. Am J Obstet Gynecol 2003; 189: 519–525
   PubMed Web of Science ®Google Scholar
• Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon B H, Edwin S, Mazor M, Maymon E, Berry S. Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002; 187: 1125–1130
   PubMed Web of Science ®Google Scholar
• Simhan H N, Caritis S N, Krohn M A, Hillier S L. The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol 2005; 192: 213–218
   PubMedGoogle Scholar
• Fortunato S J, Menon R, Lombardi S J. MMP/TIMP imbalance in amniotic fluid during PROM: An indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999; 27: 362–368
   PubMed Web of Science ®Google Scholar
• Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung disease. Free Radic Biol Med 1996; 21: 669–681
   PubMed Web of Science ®Google Scholar
• Mackenzie A P, Schatz F, Krikun G, Funai E F, Kadner S, Lockwood C J. Mechanisms of abruption-induced premature rupture of the fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromolysin-1) expression. Am J Obstet Gynecol 2004; 191: 1996–2001
   PubMed Web of Science ®Google Scholar
• Phipps R P. Atherosclerosis: The emerging role of inflammation and the CD40–CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930–6932
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato S J. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig 2004; 11: 427–437
   PubMedGoogle Scholar
• Menon R, Fortunato S J. Fetal membrane inflammatory cytokines: A switching mechanism between preterm premature rupture of the membranes and preterm labor pathways. J Perinat Med 2004; 32: 391–399
   PubMed Web of Science ®Google Scholar
• Tucker J M, Goldenberg R L, Davis R O, Copper R L, Winkler C L, Hauth J C. Etiologies of preterm birth in an indigent population: Is prevention a logical expectation?. Obstet Gynecol 1991; 77: 343–347
   PubMed Web of Science ®Google Scholar
• Locksmith G, Duff P. Infection, antibiotics and preterm delivery. Semin Perinatol 2001; 25: 295–309
   PubMedGoogle Scholar
• Thinkhamrop J, Hofmeyr G J, Adetoro O, Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality. Cochrane Database Syst Rev 2002, 4
   PubMedGoogle Scholar
• Nelson D B, Macones G. Bacterial vaginosis and pregnancy: Current findings and future directions. Epidemiol Rev 2002; 24: 102–108
   PubMed Web of Science ®Google Scholar
• McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005, 1
   Google Scholar
• Johnson J W, Austin K L, Jones G S, Davis G H, King T M. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 293: 675–680
   PubMed Web of Science ®Google Scholar
• Johnson J W, Lee P A, Zachary A S, Calhoun S, Migeon C J. High-risk prematurity—progestin treatment and steroid studies. Obstet Gynecol 1979; 54: 412–418
   PubMedGoogle Scholar
• Meis P J, Klebanoff M, Thom E, Dombrowski M P, Sibai B, Moawad A H, Spong C Y, Hauth J C, Miodovnik M, Varner M W, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–2385
   PubMed Web of Science ®Google Scholar
• da Fonseca E B, Bittar R E, Carvalho M HB, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–424
   PubMed Web of Science ®Google Scholar
• MRC/RCOG Working Party on Cervical Cerclage. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists. Multicentre randomised trial of cervical cerclage. Br J Obstet Gynaecol 1993; 100: 516–523
   PubMedGoogle Scholar
• Lazar P, Gueguen S, Dreyfus J, Renaud R, Pontonnier G, Papiernik E. Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol 1984; 91: 731–735
   PubMedGoogle Scholar
• Rush R W, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A. A randomized controlled trial of cervical cerclage in women at high-risk of spontaneous preterm delivery. Br J Obstet Gynaecol 1984; 91: 724–730
   PubMedGoogle Scholar
• Dor J, Shalev J, Mashiach S, Blankstein J, Serr D M. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following induced ovulation. Gynecol Obstet Invest 1982; 13: 55–60
   PubMed Web of Science ®Google Scholar
• Rust O A, Atlas R O, Reed J, van Gaalen J, Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: Why cerclage therapy may not help. Am J Obstet Gynecol 2001; 185: 1098–1105
   PubMed Web of Science ®Google Scholar
• To M S, Alfirevic Z, Heath V C, Cicero S, Cacho A M, Williamson P R, Nicolaides K H, Fetal Medicine Foundation Second Trimester Screening Group. Cervical cerclage for prevention of preterm delivery in women with short cervix: Randomised controlled trial. Lancet 2004; 363: 1849–1853
   PubMed Web of Science ®Google Scholar
• Althuisius S M, Dekker G A, Hummel P, Bekedam D J, van Geijn H P. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): Therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185: 1106–1112
   PubMed Web of Science ®Google Scholar
• Casanueva E, Vadillo-Ortega F, Pfeffer F, Tejero E. Vitamin C and premature rupture of chorioamniotic membranes. Nutr Res 1998; 18: 241–245
   Google Scholar
• Stuart E L, Evans G S, Lin Y S, Powers H J. Reduced collagen and ascorbic acid concentrations and increased proteolytic susceptibility with prelabor fetal membrane rupture in women. Biol Reprod 2005; 72: 230–235
   PubMed Web of Science ®Google Scholar
• Steyn P S, Odendaal H J, Schoeman J, Stander C, Fanie N, Grove D. A randomized, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labour. J Obstet Gynecol 2003; 23: 150–155
   PubMedGoogle Scholar
• Casanueva E, Carmina R, Maricruz T, Morales R M, Pfeffer F, Vilchis P. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: A randomized trial. Am J Clin Nutr 2005; 81: 859–863
   PubMed Web of Science ®Google Scholar
• Clayton D, McKeigue P M. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356–1360
   PubMed Web of Science ®Google Scholar
• Macones G A, Parry S, Elkousy M, Clothier B, Ural S H, Strauss J F. A polymorphism in the promoter region of TNF and bacterial vaginosis: Preliminary evidence of gene–environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 2004; 190: 1504–1508
   PubMed Web of Science ®Google Scholar
• Carey J C, Klebanoff M A. What have we learned about vaginal infections and preterm birth?. Semin Perinatol 2003; 27: 212–216
   PubMed Web of Science ®Google Scholar
• Erichsen H C, Engel S A, Eck P K, Welch R, Yeager M, Levine M, Siega-Riz A M, Olshan A F, Chanock S J. Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol 2006; 163: 245–254
   PubMed Web of Science ®Google Scholar
• How H, Huang Z H, Zuo J, Lei Z M, Spinnato J A. Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies. Obstet Gynecol 1995; 86: 936–940
   PubMedGoogle Scholar
• Henderson D, Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset. Am J Obstet Gynecol 2001; 185: 579–585
   PubMed Web of Science ®Google Scholar
• Shynlova O, Mitchell J A, Tsampalieros A, Langille B L, Lye S J. Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium. Biol Reprod 2004; 70: 986–992
   PubMedGoogle Scholar
• Hao K, Wang X, Niu T, Xu X, Li A, Chang W, Wang L, Li G, Laird N, Xu X. A candidate gene association study on preterm delivery: Application of high-throughput genotyping technology and advanced statistical methods. Hum Mol Genet 2004; 13: 683–691
   PubMed Web of Science ®Google Scholar
• Ferrand P E, Parry S, Sammel M, Macones G A, Kuivaniemi H, Romero R, Strauss J F. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002; 8: 494–501
   PubMed Web of Science ®Google Scholar
• Kalish R B, Nguyen D P, Santosh V, Gupta M, Perni S C, Witkin S S. A single nucleotide A > G polymorphism at position −670 in the Fas gene promoter: Relationship to preterm premature rupture of fetal membranes in multifetal pregnancies. Am J Obstet Gynecol 2005; 192: 208–212
   PubMed Web of Science ®Google Scholar
• Kalish R B, Vardhana S, Gupta M, Perni S C, Chasen S T, Witkin S S. Polymorphisms in the tumor necrosis factor-alpha gene at position −308 and the inducible 70-kd heat shock protein gene at position +1267 in multifetal pregnancies and preterm premature rupture of fetal membranes. Am J Obstet Gynecol 2004; 191: 1368–1374
   PubMedGoogle Scholar
• Kalish R B, Vardhana S, Gupta M, Chasen S T, Perni S C, Witkin S S. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy outcome. Am J Obstet Gynecol 2003; 189: 911–914
   PubMedGoogle Scholar
• Wang H, Parry S, Macones G, Sammel M D, Ferrand P E, Kuivaniemi H, Tromp G, Halder I, Shriver M D, Romero R, et al. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet 2004; 13: 2659–2669
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, Romero R, Strauss J F. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002; 277: 6296–6302
   PubMed Web of Science ®Google Scholar